Detalles de la búsqueda
1.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Breast Cancer Res Treat;
204(3): 453-463, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180699
2.
Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial.
Cancer;
129(16): 2568-2580, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082910
3.
Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.
Ann Surg Oncol;
30(3): 1678-1686, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371582
4.
Radiomics model of diffusion-weighted whole-body imaging with background signal suppression (DWIBS) for predicting axillary lymph node status in breast cancer.
J Xray Sci Technol;
31(3): 627-640, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038802
5.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci;
113(9): 3169-3179, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35754298
6.
Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean Cohorts.
Biol Pharm Bull;
45(8): 1198-1202, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908902
7.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Int J Clin Oncol;
27(2): 281-300, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022887
8.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.
Int J Clin Oncol;
27(2): 265-280, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973107
9.
The possible effects of the Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 on the practice of fertility preservation in female cancer patients in Japan.
Reprod Med Biol;
21(1): e12453, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35386371
10.
Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Ann Surg Oncol;
28(5): 2545-2552, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021710
11.
Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.
Jpn J Clin Oncol;
51(3): 492-497, 2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33377156
12.
[Clinical Significance of the Curative Effect after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer-Correlation to Prognosis].
Gan To Kagaku Ryoho;
47(10): 1449-1455, 2020 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-33130739
13.
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.
Br J Cancer;
120(5): 475-480, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745582
14.
Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
Ann Surg Oncol;
26(8): 2475-2485, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102090
15.
Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study.
Oncology;
96(6): 309-317, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30893699
16.
Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).
Jpn J Clin Oncol;
49(12): 1083-1091, 2019 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31612909
17.
A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese Population.
Biol Pharm Bull;
42(12): 2045-2053, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31597885
18.
A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients.
J Obstet Gynaecol Res;
45(10): 2021-2028, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31364239
19.
Grading System to Categorize Breast MRI in BI-RADS 5th Edition: A Multivariate Study of Breast Mass Descriptors in Terms of Probability of Malignancy.
AJR Am J Roentgenol;
210(3): W118-W127, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381382
20.
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.
Jpn J Clin Oncol;
48(9): 855-859, 2018 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020510